LEADER 02236nam  2200613 a 450 
001 9910817036303321
005 20240131173322.0
010   $a1-280-24696-0
010   $a9786610246960
010   $a0-309-57203-7
010   $a0-585-21783-1
035   $a(CKB)111004366656318
035   $a(OCoLC)607691872
035   $a(CaPaEBR)ebrary10056826
035   $a(SSID)ssj0000126553
035   $a(PQKBManifestationID)11137057
035   $a(PQKBTitleCode)TC0000126553
035   $a(PQKBWorkID)10046478
035   $a(PQKB)10027455
035   $a(MiAaPQ)EBC3376552
035   $a(EXLCZ)99111004366656318
100   $a20150424d1982||||  s||            |
101 0 $aeng
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCompetitive Status of the U.S. Pharmaceutical Industry: The Influences of Technology in Determining International Industrial Competitive Advantage$b[electronic resource]
210   $aWashington, D.C. $cNational Academy Press$d1982
215   $a1 online resource (114 p.)
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-309-03396-9 
606   $aPharmaceutical industry$zUnited States
606   $aPharmaceutical industry
606   $aCompetition, International
606   $aBUSINESS & ECONOMICS$2bisac
606   $aIndustries / General$2bisac
606   $aBusiness & Economics$2HILCC
606   $aIndustries$2HILCC
615  0$aPharmaceutical industry
615  0$aPharmaceutical industry.
615  0$aCompetition, International.
615  7$aBUSINESS & ECONOMICS
615  7$aIndustries / General
615  7$aBusiness & Economics
615  7$aIndustries
676   $a338.4/76151/0973
701   $aThomas$b Lacy Glenn$01630399
712 02$aCommission on Engineering and Technical Systems
712 02$aCommittee on Technology and International Economic and Trade Issues of the Office of the Foreign Secretary
801  0$bPQKB
906   $aBOOK
912   $a9910817036303321
996   $aCompetitive Status of the U.S. Pharmaceutical Industry: The Influences of Technology in Determining International Industrial Competitive Advantage$93968704
997   $aUNINA